FDA CTP Names New Compliance and Enforcement Director
Tobacco manufacturers should prepare for continued regulatory scrutiny under the office's new leadership.
Updated on Oct. 21, 2026 in People
Live Poll
Do you trust federal agencies more when they appoint directors with extensive private-sector experience?
The FDA Center for Tobacco Products (CTP) has appointed Jessica Zeller as the director of its Office of Compliance and Enforcement. Zeller brings 20 years of legal experience to the regulatory role, overseeing compliance operations for the agency's tobacco oversight program.
Why it matters
The appointment places a veteran legal and regulatory professional in charge of the CTP office responsible for enforcing compliance standards within the tobacco industry. Operators in this sector should expect a focus on regulatory rigor given Zeller's extensive history in FDA counsel and quality-focused corporate leadership.
The appointment marks a transition for the CTP's Office of Compliance and Enforcement following a selection process involving multiple interview panels. Zeller brings 20 years of professional legal experience to the role, drawing on her past tenures at both the FDA and in the private sector.
The players
Jessica Zeller
The new director of the FDA Center for Tobacco Products' Office of Compliance and Enforcement who has 20 years of legal experience.
FDA Center for Tobacco Products
The federal agency responsible for regulating the manufacture, distribution, and marketing of tobacco products.
Edwards Lifesciences
A medical technology company specializing in patient-focused innovations for structural heart disease and critical care monitoring.
The details
Zeller assumes the directorship after having previously served as the inaugural deputy director for the same office and as the first ombudsman for the FDA Office of Regulatory Affairs. Her professional background includes corporate counsel roles at Edwards Lifesciences and trial attorney positions within the FDA Office of Chief Counsel. She successfully navigated the senior executive service process and agency ethics reviews to secure the appointment.
Timeline
October 20, 2026: The FDA announced the appointment of Jessica Zeller.
Market Landscape
This appointment aligns with the long-term regulatory strategy of the FDA Center for Tobacco Products' enforcement mandate. It signals a prioritization of deep agency expertise as the CTP continues to manage complex compliance oversight for the tobacco industry.
Business operators in the tobacco sector should monitor upcoming guidance or enforcement notices coming from the Office of Compliance and Enforcement. Review internal compliance protocols now to ensure alignment with existing FDA standards before potential changes in departmental strategy take hold.
The takeaway
Zeller’s return to the CTP following a tenure in private sector quality and counsel suggests a firm approach to regulatory compliance for industry participants. Keep an eye on upcoming agency bulletins and enforcement memos to understand how this new leadership will interpret existing oversight mandates.
Further reading
For more on shifts in agency leadership and regulatory oversight, visit People.
Live Poll
Do you trust federal agencies more when they appoint directors with extensive private-sector experience?
